Mucormycosis: What emergency physicians need to know?

American Journal of Emergency Medicine

Volumn 33, Issue 12, 2015, Pages 1823-1825

  Long, Brit ^a   Koyfman, Alex ^b  

^a SAN ANTONIO MILITARY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT;

COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONSULTATION; CRANIAL NERVE PARALYSIS; DEBRIDEMENT; DIABETIC PATIENT; DISEASE PREDISPOSITION; EMERGENCY PHYSICIAN; EMERGENCY WARD; FEVER; FUNGUS GROWTH; HEADACHE; HUMAN; HYPERBARIC OXYGEN; IMMUNOCOMPROMIZED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; MENTAL HEALTH; MUCORMYCOSIS; NECROSIS; NONHUMAN; NOSE ULCER; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOPLEGIA; ORBIT TUMOR; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SINUSITIS; VISUAL DISORDER; DIABETES COMPLICATIONS; EMERGENCY HEALTH SERVICE; IMMUNOCOMPROMISED PATIENT;

ANTIFUNGAL AGENTS; DEBRIDEMENT; DIABETES COMPLICATIONS; EMERGENCY SERVICE, HOSPITAL; HUMANS; IMMUNOCOMPROMISED HOST; MUCORMYCOSIS; PROGNOSIS; RISK FACTORS;

EID: 84951138117     PISSN: 07356757     EISSN: 15328171     Source Type: Journal    
DOI: 10.1016/j.ajem.2015.08.037     Document Type: Review

References (34)

1. C.A. Kauffman, and A.N. Malani Zygomycosis: an emerging fungal infection with new options for management Curr Infect Dis Rep 9 2007 435
2. B. Spellberg, T.J. Walsh, D.P. Kontoyiannis, D.P. Kontoylannis, J. Edwards Jr., A.S. Ibrahim, and et al. Recent advances in the management of mucormycosis: from bench to bedside Clin Infect Dis 48 2009 1743
3. M.M. Roden, T.E. Zaoutis, W.L. Buchanan, T.A. Knudsen, T.A. Sarkisova, R.L. Schaufele, and et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases Clin Infect Dis 41 2005 634
4. G.R. Gale, and A.M. Welch Studies of opportunistic fungi. I. Inhibition of Rhizopus oryzae by human serum Am J Med Sci 241 1961 604
5. J.S. McNulty Rhinocerebral mucormycosis: predisposing factors Laryngoscope 92 1982 1140
6. J.R. Boelaert, M. de Locht, J. Van Cutsem, V. Kerrels, B. Cantinieaux, A. Verdonck, and et al. Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies J Clin Invest 91 1993 1979
7. B.J. Ferguson Mucormycosis of the nose and paranasal sinuses Otolaryngol Clin North Am 33 2000 349
8. R.A. Yohai, J.D. Bullock, A.A. Aziz, and R.J. Markert Survival factors in rhino-orbital-cerebral mucormycosis Surv Ophthalmol 39 1994 3
9. F.Y. Lee, S.B. Mossad, and K.A. Adal Pulmonary mucormycosis: the last 30 years Arch Intern Med 159 1999 1301
10. M. Tedder, J.A. Spratt, M.P. Anstadt, S.S. Hegde, S.D. Tedder, and J.E. Lowe Pulmonary mucormycosis: results of medical and surgical therapy Ann Thorac Surg 57 1994 1044
11. F.P. Agha, H.H. Lee, C.R. Boland, and S.F. Bradley Mucormycoma of the colon: early diagnosis and successful management AJR Am J Roentgenol 145 1985 739
12. R.D. Adam, G. Hunter, J. DiTomasso, and G. Comerci Jr. Mucormycosis: emerging prominence of cutaneous infections Clin Infect Dis 19 1994 67
13. F. Wirth, R. Perry, A. Eskenazi, R. Schwalbe, and G. Kao Cutaneous mucormycosis with subsequent visceral dissemination in a child with neutropenia: a case report and review of the pediatric literature J Am Acad Dermatol 36 1997 336
14. E. Levy, and M.J. Bia Isolated renal mucormycosis: case report and review J Am Soc Nephrol 5 1995 2014
15. S.E. Nagy-Agren, P. Chu, G.J. Smith, H.A. Waskin, and F.L. Altice Zygomycosis (mucormycosis) and HIV infection: report of three cases and review J Acquir Immune Defic Syndr Hum Retrovirol 10 1995 441
16. S.U. Siddiqi, and J.D. Freedman Isolated central nervous system mucormycosis South Med J 87 1994 997
17. R.J. Hopkins, M. Rothman, A. Fiore, and S.E. Goldblum Cerebral mucormycosis associated with intravenous drug use: three case reports and review Clin Infect Dis 19 1994 1133
18. G.M. Stave, T. Heimberger, and T.M. Kerkering Zygomycosis of the basal ganglia in intravenous drug users Am J Med 86 1989 115
19. S.P. Hammond, R. Bialek, D.A. Milner, E.M. Petschnigg, L.R. Baden, and F.M. Marty Molecular methods to improve diagnosis and identification of mucormycosis J Clin Microbiol 49 2011 2151
20. T.J. Walsh, M.N. Gamaletsou, M.R. McGinnis, R.T. Hayden, and D.P. Kontoyiannis Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis) Clin Infect Dis 54 Suppl. 1 2012 S55
21. N. Saltoğlu, Y. Taşova, S. Zorludemir, and I.H. Dündar Rhinocerebral zygomycosis treated with liposomal amphotericin B and surgery Mycoses 41 1998 45
22. G. Chamilos, E.M. Marom, R.E. Lewis, M.S. Lionakis, and D.P. Kontoyiannis Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer Clin Infect Dis 41 2005 60
23. H. Wahba, M.T. Truong, X. Lei, D.P. Kontoyiannis, and E.M. Marom Reversed halo sign in invasive pulmonary fungal infections Clin Infect Dis 46 2008 1733
24. D.P. Kontoyiannis, V.C. Wessel, G.P. Bodey, and K.V. Rolston Zygomycosis in the 1990s in a tertiary-care cancer center Clin Infect Dis 30 2000 851
25. M. McCarthy, A. Rosengart, A.N. Schuetz, D.P. Kontoyiannis, and T.J. Walsh Mold infections of the central nervous system N Engl J Med 371 2014 150
26. G. Chamilos, R.E. Lewis, and D.P. Kontoyiannis Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis Clin Infect Dis 47 2008 503
27. D.P. Kontoyiannis, and R.E. Lewis How I treat mucormycosis Blood 118 2011 1216
28. R.B. Brown, J.H. Johnson, J.M. Kessinger, and W.C. Sealy Bronchovascular mucormycosis in the diabetic: an urgent surgical problem Ann Thorac Surg 53 1992 854
29. E.K. Spanakis, G. Aperis, and E. Mylonakis New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage Clin Infect Dis 43 2006 1060
30. Q.N. Sun, A.W. Fothergill, D.I. McCarthy, M.G. Rinaldi, and J.R. Graybill In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes Antimicrob Agents Chemother 46 2002 1581
31. B. Spellberg, A.S. Ibrahim, P.V. Chin-Hong, D.P. Kontoyiannis, M.I. Morris, J.R. Perfect, and et al. The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial J Antimicrob Chemother 67 2012 715
32. Y. Bentur, A. Shupak, Y. Ramon, A. Abramovich, G. Wolfin, H. Stein, and et al. Hyperbaric oxygen therapy for cutaneous/soft-tissue zygomycosis complicating diabetes mellitus Plast Reconstr Surg 102 1998 822
33. B.E. Weprin, W.A. Hall, J. Goodman, and G.L. Adams Long-term survival in rhinocerebral mucormycosis. Case report J Neurosurg 88 1998 570
34. P.D. Shah, K.R. Peters, and P.D. Reuman Recovery from rhinocerebral mucormycosis with carotid artery occlusion: a pediatric case and review of the literature Pediatr Infect Dis J 16 1997 68